Cargando…
CORRIGENDUM: Clinical observation of patients with Fabry disease after switching from agalsidase beta (Fabrazyme) to agalsidase alfa (Replagal)
Formato: | Online Artículo Texto |
---|---|
Lenguaje: | English |
Publicado: |
Nature Publishing Group
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4030589/ http://dx.doi.org/10.1038/gim.2012.62 |
_version_ | 1782317410463776768 |
---|---|
collection | PubMed |
description | |
format | Online Article Text |
id | pubmed-4030589 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2012 |
publisher | Nature Publishing Group |
record_format | MEDLINE/PubMed |
spelling | pubmed-40305892014-05-27 CORRIGENDUM: Clinical observation of patients with Fabry disease after switching from agalsidase beta (Fabrazyme) to agalsidase alfa (Replagal) Genet Med Corrigendum Nature Publishing Group 2012-08 2012-08-03 /pmc/articles/PMC4030589/ http://dx.doi.org/10.1038/gim.2012.62 Text en Copyright © 2012 American College of Medical Genetics and Genomics |
spellingShingle | Corrigendum CORRIGENDUM: Clinical observation of patients with Fabry disease after switching from agalsidase beta (Fabrazyme) to agalsidase alfa (Replagal) |
title | CORRIGENDUM: Clinical observation of patients with Fabry disease after switching from agalsidase beta (Fabrazyme) to agalsidase alfa (Replagal) |
title_full | CORRIGENDUM: Clinical observation of patients with Fabry disease after switching from agalsidase beta (Fabrazyme) to agalsidase alfa (Replagal) |
title_fullStr | CORRIGENDUM: Clinical observation of patients with Fabry disease after switching from agalsidase beta (Fabrazyme) to agalsidase alfa (Replagal) |
title_full_unstemmed | CORRIGENDUM: Clinical observation of patients with Fabry disease after switching from agalsidase beta (Fabrazyme) to agalsidase alfa (Replagal) |
title_short | CORRIGENDUM: Clinical observation of patients with Fabry disease after switching from agalsidase beta (Fabrazyme) to agalsidase alfa (Replagal) |
title_sort | corrigendum: clinical observation of patients with fabry disease after switching from agalsidase beta (fabrazyme) to agalsidase alfa (replagal) |
topic | Corrigendum |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4030589/ http://dx.doi.org/10.1038/gim.2012.62 |